Author:
Trabelsi H.,Hassen I.E.,Bouabdallah S.,Bouzouita K.,Safta F.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An inclusive exploration of forced degradation analysis of some therapeutic categories of drugs in the last decade;Journal of the Scientific Society;2023
2. Forced Degradation Studies of Drospirenone: Isolation and Characterization of Degradation Products;Indian Journal of Pharmaceutical Education and Research;2021-11-09
3. Development and validation of a stability‐indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple‐combination dosage form using factorial design of experiments;Biomedical Chromatography;2021-06-28
4. Identification, isolation, structural characterisation, synthesis and in silico toxicity prediction of the alkaline hydrolytic degradation product of brivaracetam by using LC-PDA, preparative HPLC, LC/HESI/LTQ, FTIR, and 1H NMR;Analytical Methods;2020
5. Dried Blood Spots Combined With Ultra–High-Performance Liquid Chromatography–Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites;Therapeutic Drug Monitoring;2017-08